Clinical trials
Completed Triple Negative Breast Neoplasms trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor Research Institute | 1 |
| Emory University | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Institut Claudius Regaud | 1 |
| Institut Curie | 1 |
| Luz A. Venta, MD | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
| Stanford University | 1 |
| University of Alabama at Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 9 |
| Breast Neoplasms | 4 |
| Bone Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
| Colonic Neoplasms | 1 |
| Disease Progression | 1 |
| Esophageal Neoplasms | 1 |
| Hereditary Breast and Ovarian Cancer Syndrome | 1 |
| Leukemia, Myeloid, Acute | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.